Schedule 13G ownership disclosure

Anthera Pharmaceuticals Inc (NV)

Security class unavailable · CUSIP: 03674U300

Event date: 2017-03-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
368,351
Percent of class
3.6600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-044421
Form type
SC 13G/A
Filer
Anthera Pharmaceuticals Inc
CIK
CIK 1316175
Filed
Jul 11, 2017
Reporting period
Mar 17, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub